Detalles de la búsqueda
1.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med
; 13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
2.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC Cancer
; 13: 163, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537287
3.
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC Med
; 9: 10, 2011 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21281463
4.
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.
Clin Breast Cancer
; 16(4): 291-298.e3, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26791750
Resultados
1 -
4
de 4
1
Próxima >
>>